Formycon Receives Positive CHMP Opinion for FYB203 (Aflibercept), a Biosimilar Candidate to Eylea® under the Tradenames AHZANTIVE® and Baiama®

Written by Kirsten Ruehl on 18th November 2024. Posted in Client News.